Intravenous Alteplase for Stroke in Those Older Than 80 Years Old

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Stroke

• Publication date

  2010-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.110.581884PMID 20930163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous Thrombolysis with Rt-Pa in Acute Stroke Patients Aged ≥ 80 Years

  2009cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

  2008cited by this paper
• Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)

  2008cited by this paper
• Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.

  2008cited by this paper
• The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

  2008cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics

  2007cited by this paper
• Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years.

  2007cited by this paper
• Intravenous Thrombolysis with rt-PA in Acute Ischemic Stroke Patients Aged Older than 80 Years in Italy

  2007cited by this paper
• Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age--a systematic review across cohort studies.

  2006cited by this paper
• Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients

  2005cited by this paper
• Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study.

  2004cited by this paper
• Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.

  2000cited by this paper
• Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group.

  1999cited by this paper
• Two-sided confidence intervals for the single proportion: comparison of seven methods.

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• The European Cooperative Acute Stroke Study (ECASS)

  1993cited by this paper

• Prediction of hemorrhagic transformation after intravenous thrombolysis in acute anterior circulation ischemic stroke through radiomics-based machine learning models.

  2026cites this paper
• Observation on the Clinical Efficacy of Intravenous Thrombolysis with Alteplase in Acute Ischemic Stroke across Different Age Groups

  2025cites this paper
• Off-label thrombolysis in acute ischemic stroke patients: Frequencies and outcome compared to on-label and no treatment

  2025cites this paper
• Safe Implementation of Treatments in Stroke: a study on intravenous thrombolysis in patients over 80 years of age with acute ischaemic stroke

  2025cites this paper
• Comparison of the Clinical Outcomes Between Reperfusion and Non-Reperfusion Therapy in Elderly Patients with Acute Ischemic Stroke

  2024cites this paper
• Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke

  2024cites this paper
• Clinical and Subclinical Characteristics in Adults with Acute Ischemic Stroke Before Revascularization at E Hospital

  2024cites this paper
• Risk factors of hemorrhagic transformation in acute ischaemic stroke: A systematic review and meta-analysis

  2023cites this paper
• Monitoring risk and preventing ischemic stroke in the very old

  2023cites this paper
• Tenecteplase 0.4 mg/kg in moderate and severe acute ischemic stroke: A pooled analysis of NOR-TEST & NOR-TEST 2A

  2023cites this paper
• A new clinical score to predict the possibility of stroke patients receiving intravenous thrombolysis.

  2023cites this paper
• Efficacy and safety of intravenous thrombolytic therapy in patients over eighty years

  2023cites this paper
• Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR‐TEST and NOR‐TEST 2A

  2023cites this paper
• Ipsilateral and contralateral carotid stenosis contribute to the outcome of reperfusion treatment for ischemic stroke

  2023cites this paper
• Efficacy and safety of reperfusion treatments in middle-old and oldest-old stroke patients

  2022cites this paper
• Trends in Use, Outcomes, and Disparities in Endovascular Thrombectomy in US Patients With Stroke Aged 80 Years and Older Compared With Younger Patients

  2022cites this paper
• Comparison of the Outcome of Altplas Administration after Acute Ischemic Stroke in Patients Over 80 Years and Under 80 Years Admitted

  2022cites this paper
• Clinical Outcomes after Intravenous Alteplase in Elderly Patients with Acute Ischaemic Stroke: A Retrospective Analysis of Patients Treated at a Tertiary Neurology Centre in England from 2013 to 2018

  2021cites this paper
• Experiences With Intravenous Thrombolysis in Acute Ischemic Stroke by Elderly Patients–A “Real World Scenario”

  2021cites this paper
• Reperfusion therapy for acute ischemic stroke in older people: An observational real‐life study

  2021cites this paper
• Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke

  2021cites this paper
• Reply Letter to Evolving the Proposed HEMS Stroke Triaging Tool.

  2021cites this paper
• Registry-Based Stroke Research

  2021cites this paper
• Pharmacodynamics and Pharmacokinetics of Stroke Therapy

  2021cites this paper
• Blood Pressure Balance as a Marker for Early Detection of Cerebral Infarction and a Criterion for Inclusion/Exclusion from Acupuncture Treatment

  2021cites this paper
• Reperfusion treatments for acute ischemic stroke in nonagenarians

  2020cites this paper
• Stroke in the Middle-East and North Africa: A 2-year prospective observational study of intravenous thrombolysis treatment in the region. Results from the SITS-MENA Registry

  2020cites this paper
• Functional Outcomes of Intravenous Thrombolysis in Octogenarians and Nonagenarians Through Telestroke: Single-Center Experience

  2020cites this paper
• Intravenous thrombolysis in the elderly is facilitated by a tele-stroke network: A cross-sectional study.

  2020cites this paper
• COVID‐19–Associated Encephalopathy and Cytokine‐Mediated Neuroinflammation

  2020cites this paper
• Reply to “Prior Dual Antiplatelet Therapy and Thrombolysis in Acute Stroke”

  2020cites this paper
• Accidente cerebrovascular en el paciente anciano

  2020cites this paper
• Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients

  2020cites this paper
• Accident vasculaire cérébral chez le sujet âgé

  2019cites this paper
• Epidemiology and Outcomes of Ischemic Stroke and Transient Ischemic Attack in the Adult and Geriatric Population.

  2019cites this paper
• External Validation of START nomogram to predict 3-Month unfavorable outcome in Chinese acute stroke patients.

  2019cites this paper
• Prestroke Conditions of Acute Ischemic Stroke Patients are Associated with Functional Outcome after Mechanical Thrombectomy.

  2019cites this paper
• [Thrombolytic therapy of ischemic stroke].

  2018cites this paper
• Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.

  2018cites this paper
• Postdischarge quality of care: do age disparities exist among Department of Veterans Affairs ischemic stroke patients?

  2018cites this paper
• Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study

  2018cites this paper
• Practice Patterns and Barriers for Intravenous Thrombolysis: A Survey of Neurologists in Saudi Arabia

  2018cites this paper
• Acute Thrombectomy for Cerebral Infarction: Comparative Study between Patients over 85 Years Old and Those below 85 Years Old

  2018cites this paper
• Predictors of symptomatic intracranial haemorrhage in off‐label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry

  2018cites this paper
• Organizational models for thrombolysis in acute ischemic stroke

  2018cites this paper
• Factors that influence clinicians’ decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment

  2018cites this paper
• Clinical Outcome of Ischemic Stroke in Old Patients Versus Oldest-Old.

  2018cites this paper
• Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability

  2018cites this paper
• Professional guideline versus product label selection for treatment with IV thrombolysis: An analysis from SITS registry

  2018cites this paper
• Trombólise Intravenosa no Acidente Vascular Cerebral Isquémico Agudo Depois dos 80 Anos

  2018cites this paper
• Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial

  2017cites this paper
• Significances and Outcomes of Mechanical Thrombectomy for Acute Infarction in Very Elderly Patients: A Single Center Experience

  2017cites this paper
• Predictors of Symptomatic Intracranial Hemorrhage in Off-label Thrombolysis : an Analysis of the SITS registry

  2017cites this paper
• Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate

  2017cites this paper
• Outcome after stroke thrombolysis in patients >80 years treated within 3 hours vs >3–4.5 hours

  2017cites this paper
• Validation of the mSOAR and SOAR scores to predict early mortality in Chinese acute stroke patients

  2017cites this paper
• Evidence Review on Pathways of Hyperacute Stroke Care

  2017cites this paper
• Sex differences in the presentation of stroke.

  2017cites this paper
• Predictors of Need for Critical Care Support, Adverse Events, and Outcome after Stroke Thrombolysis.

  2017cites this paper
• Ischämischer Schlaganfall

  2017influential citation
• Stroke in Frail Older People

  2017cites this paper
• Endovascular stroke treatment in a small‐volume stroke center

  2017cites this paper
• Factors that influence variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke: results of a discrete choice experiment

  2017cites this paper
• Stent retriever thrombectomy for acute ischemic stroke: Indications, results and management in 2015.

  2016cites this paper
• Endovascular mechanical recanalization of acute ischaemic stroke in octogenarians

  2016cites this paper
• Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years

  2016cites this paper
• Intravenous thrombolysis for acute ischaemic stroke in the elderly: data from the Baden‐Wuerttemberg stroke registry

  2016cites this paper
• AHA elegibility for thrombolysis

  2016cites this paper
• Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2016cites this paper
• Association of time on outcome after intravenous thrombolysis in the elderly in a telestroke network

  2016cites this paper
• Thrombolysis in Patients Aged over 80 Years Is Equally Effective and Safe.

  2016cites this paper
• Stent Retriever-Based Thrombectomy in Octogenarians

  2016cites this paper
• 高齢化率の高い一地方病院におけるrt-PA 静注療法の取り組み

  2016cites this paper
• Tenecteplase and alteplase in acute ischaemic stroke thrombolysis : clinical and imaging study

  2016cites this paper
• Mechanical thrombectomy for acute ischemic stroke

  2016cites this paper
• Changes in European Label and Guideline Adherence After Updated Recommendations for Stroke Thrombolysis: Results From the Safe Implementation of Treatments in Stroke Registry

  2015cites this paper
• Intravenous Thrombolysis for Acute Ischemic Stroke in the Elderly: An Italian Cohort Study in a “Real World” Setting

  2015cites this paper
• Recanalization in cerebral ischemia

  2015cites this paper
• Early Administration of Therapeutic Anticoagulation Following Intravenous Thrombolysis for Acute Cardiogenic Embolic Stroke Caused by Left Ventricular Thrombus: Case Report and Topic Review

  2015cites this paper
• IV thrombolysis in very severe and severe ischemic stroke

  2015cites this paper
• Treatment of acute stroke: an update

  2015cites this paper
• Brain CT signs and the effect of alteplase after stroke.

  2015cites this paper
• Predicting functional outcome and symptomatic intracranial hemorrhage in patients with acute ischemic stroke: a glimpse into the crystal ball?

  2015cites this paper
• Prehospital identification and priority of acute stroke

  2015cites this paper
• The Effect of Time to Treatment on Outcome in Very Elderly Thrombolysed Stroke Patients

  2014cites this paper
• Acute revascularization by endovascular therapy for stroke in the very elderly

  2014cites this paper
• Acute ischaemic stroke outcomes following mechanical thrombectomy in the elderly versus their younger counterpart: a retrospective cohort study

  2014cites this paper
• Intravenous thrombolysis in patients aged more than 80 years in the three rural hospitals in southeast Poland: An observational study

  2014cites this paper
• Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for stroke

  2014cites this paper
• Mortality-related factors in ischemic stroke patients 80 years of age and older

  2014cites this paper
• Perfusion of Ischemic Brain in Young and Aged Animals: A Laser Speckle Flowmetry Study

  2014cites this paper
• Age dependency of safety and outcome of endovascular therapy for acute stroke

  2014cites this paper
• Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository

  2014cites this paper
• Intracerebral hemorrhage in patients treated with intravenous thrombolysis for acute ischemic stroke

  2014cites this paper
• Benefit or harm: does age matter in stroke outcome after thrombolysis?

  2014cites this paper
• Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry

  2014cites this paper
• Safety of standard-dose (.9-mg/kg) alteplase intravenous thrombolysis for acute ischemic stroke in Afro-Caribbeans, French West Indies.

  2014cites this paper
• Retrospective checking of compliance with practice guidelines for acute stroke care: a novel experiment using openEHR’s Guideline Definition Language

  2014cites this paper
• MRT- versus CT- basierte Lysetherapie beim akuten ischämischen Schlaganfall

  2014cites this paper
• Emberson, J. et al. (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data

  2014cites this paper